Food, Drugs, Healthcare, Life Sciences

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
HHS Expands Use Of AI In Detection Of Healthcare Fraud
The U.S. Department of Health and Human Services has launched a new initiative using artificial intelligence to analyze years of audit reports from federal healthcare funding recipients across all 50 states. This program, called AERO, aims to identify unaddressed audit deficiencies and combat healthcare fraud by leveraging AI tools like ChatGPT to review extensive audit documentation that would typically go unexamined.
United States Healthcare
SM
Sheppard, Mullin, Richter & Hampton LLP
See more
See more
Article
HHS Expands Use Of AI In Detection Of Healthcare Fraud
The U.S. Department of Health and Human Services has launched a new initiative using artificial intelligence to analyze years of audit reports from federal healthcare funding recipients across all 50 states. This program, called AERO, aims to identify unaddressed audit deficiencies and combat healthcare fraud by leveraging AI tools like ChatGPT to review extensive audit documentation that would typically go unexamined.
United States Healthcare
SM
Sheppard, Mullin, Richter & Hampton LLP
See more
Article
Supreme Court Clarifies Standard For Induced Infringement In Hikma v. Amarin
In a unanimous decision handed down today, the Supreme Court delivered a tactical victory for Hikma, and a measure of guidance for other generic manufacturers. In Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889, the Court held that drug manufacturer Amarin, the reference product sponsor, failed to state a claim for active inducement of patent infringement under 35 U.S.C. § 271(b).
United States IP
M
Mintz
See more